AR012340A1 - 3,4-DIHYDRO-2 (1H) -QUINAZOLINONES 4,4-DISSTITUTED USEFUL AS INHIBITORS OF THE REVERSE TRANSCRIPTASE OF HIV, COMPOSITION AND KITFARMACEUTICOS THAT CONTAIN THEM - Google Patents
3,4-DIHYDRO-2 (1H) -QUINAZOLINONES 4,4-DISSTITUTED USEFUL AS INHIBITORS OF THE REVERSE TRANSCRIPTASE OF HIV, COMPOSITION AND KITFARMACEUTICOS THAT CONTAIN THEMInfo
- Publication number
- AR012340A1 AR012340A1 ARP980101558A ARP980101558A AR012340A1 AR 012340 A1 AR012340 A1 AR 012340A1 AR P980101558 A ARP980101558 A AR P980101558A AR P980101558 A ARP980101558 A AR P980101558A AR 012340 A1 AR012340 A1 AR 012340A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- dihydro
- useful
- nr5r5a
- reverse transcriptase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invencion hace conocer 3,4-dihidro-2(1H)-quinazolinonas 4,4- disustituidas de la formula (I), o las formas estereoisoméricas, mezclasestereoisoméricas o sales apras para uso farmacéutico de las mismas, que son de utilidad como inhibidores de la transcriptasa inversa del HIV y concomposiciones farmacéuticas y kits de diagnostico que contienen a las mismas, donde: R1 es alquilo-C1-3 sustituido con 1-7 halogenos; R2 se selecciona dealquilo-C1-5 sustituido con 1-2 R4, alquenilo-C2-5 sustituido con 1-2 R4 y alquinilo-C2-5 sustituido con 1 R4; R3, en cada aparicion, se seleccionaindependientemente de alquilo-C1-4, OH, alcoxi-C1-4, F, Cl, Br, I, NR5R5a, NO2, CN, C(O)R6, NHC(O)R7 y NHC(O)NR5R5a, como alternativa, si hay dosR3 yestán unidos a átomos de carbono adyacentes, entonces se pueden combinar para formar -OCH2O-; R4 se selecciona de cicloalquilo-C3-5 sustituido con 0-2 R3,fenilo sustituido con 0-5 R3 y un sistema heterocíclico de 5-6 miembros que contienede 1-3 heteroátomos seleccionados entre O, N y S, sustituido con 0-2R3; R5 y R5a se seleccionan independientemente de H y alquilo C1-3; R6 se selecciona de H, OH, alquilo C1-4, alcoxi-C1-4, y NR5R5a; R7 se selecciona dealquilo C1-3 y alcoxi-C1-3; R8 se selecciona de H, cicloalquilo-C3-5 y alquilo C1-3 y n se selecciona de 0, 1, 2, 3 y 4.The present invention discloses 3,4-dihydro-2 (1H) -4,4-disubstitutedquinazolinones of formula (I), or the stereoisomeric forms, stereoisomeric mixtures or salts for pharmaceutical use thereof, which are useful as HIV reverse transcriptase inhibitors and pharmaceutical compositions and diagnostic kits containing the same, where: R1 is C1-3alkyl substituted with 1-7 halogens; R2 is selected from C1-5alkyl substituted with 1-2R4, C2-5alkenyl substituted by 1-2R4 and C2-5alkynyl substituted by 1R4; R3, at each occurrence, is independently selected from C1-4alkyl, OH, C1-4alkoxy, F, Cl, Br, I, NR5R5a, NO2, CN, C (O) R6, NHC (O) R7 and NHC (O) NR5R5a, alternatively, if there are twoR3s and they are attached to adjacent carbon atoms, then they can combine to form -OCH2O-; R4 is selected from C3-5-cycloalkyl substituted with 0-2 R3, phenyl substituted with 0-5 R3 and a 5-6 membered heterocyclic system containing 1-3 heteroatoms selected from O, N and S, substituted with 0- 2R3; R5 and R5a are independently selected from H and C1-3 alkyl; R6 is selected from H, OH, C1-4alkyl, C1-4alkoxy, and NR5R5a; R7 is selected from C1-3alkyl and C1-3alkoxy; R8 is selected from H, C3-5 cycloalkyl, and C1-3 alkyl and n is selected from 0, 1, 2, 3, and 4.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83854097A | 1997-04-09 | 1997-04-09 | |
| US7132298P | 1998-01-14 | 1998-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012340A1 true AR012340A1 (en) | 2000-10-18 |
Family
ID=26752095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980101558A AR012340A1 (en) | 1997-04-09 | 1998-04-06 | 3,4-DIHYDRO-2 (1H) -QUINAZOLINONES 4,4-DISSTITUTED USEFUL AS INHIBITORS OF THE REVERSE TRANSCRIPTASE OF HIV, COMPOSITION AND KITFARMACEUTICOS THAT CONTAIN THEM |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973753A2 (en) |
| JP (1) | JP2002504095A (en) |
| KR (1) | KR20010006146A (en) |
| CN (1) | CN1252063A (en) |
| AR (1) | AR012340A1 (en) |
| AU (1) | AU734928B2 (en) |
| BR (1) | BR9808513A (en) |
| CA (1) | CA2284996A1 (en) |
| EA (1) | EA001991B1 (en) |
| EE (1) | EE9900452A (en) |
| HR (1) | HRP980143A2 (en) |
| HU (1) | HUP0001446A3 (en) |
| IL (1) | IL132188A0 (en) |
| NO (1) | NO314936B1 (en) |
| NZ (1) | NZ500592A (en) |
| PL (1) | PL336305A1 (en) |
| SK (1) | SK137899A3 (en) |
| TW (1) | TW587078B (en) |
| WO (1) | WO1998045276A2 (en) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999050253A1 (en) * | 1998-03-27 | 1999-10-07 | Du Pont Pharmaceuticals Company | 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| WO2000021565A1 (en) | 1998-10-13 | 2000-04-20 | Du Pont Pharmaceuticals Company | Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent |
| WO2000029390A1 (en) * | 1998-11-19 | 2000-05-25 | Du Pont Pharmaceuticals Company | Crystalline (-)-6- chloro-4- cyclopropylethynyl- 4-trifluoromethyl- 3,4-dihydro- 2(1h)-quinazolinone |
| WO2000029391A1 (en) * | 1998-11-19 | 2000-05-25 | Du Pont Pharmaceuticals Company | Process for the preparation of quinazolinones |
| US6175009B1 (en) | 1999-11-18 | 2001-01-16 | Dupont Pharmaceuticals Company | Process for the preparation of quinazolinones |
| US6759410B1 (en) | 1999-11-23 | 2004-07-06 | Smithline Beecham Corporation | 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
| JP2003528043A (en) | 1999-11-23 | 2003-09-24 | スミスクライン・ビーチャム・コーポレイション | 3,4-Dihydro- (1H) quinazolin-2-one compounds as CSBP / p38 kinase inhibitors |
| US6555686B2 (en) * | 2000-03-23 | 2003-04-29 | Bristol-Myers Squibb Pharma | Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors |
| AU2001249161A1 (en) * | 2000-03-23 | 2001-10-03 | Bristol-Myers Squibb Pharma Company | Asymmetric synthesis of quinazolin-2-ones useful as hiv reverse transcriptase inhibitors |
| US6596729B2 (en) * | 2000-07-20 | 2003-07-22 | Bristol-Myers Squibb Company | Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| ZA200300255B (en) | 2000-07-20 | 2004-09-28 | Bristol Myers Squibb Pharma Co | Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors. |
| US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
| US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
| US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
| US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
| US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
| US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US7713214B2 (en) | 2002-04-19 | 2010-05-11 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing |
| US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
| US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
| US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
| US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
| JP2006514045A (en) * | 2002-12-16 | 2006-04-27 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | Treatment of HIV infection by combined administration of tipranavir and capravirin |
| US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
| WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
| US8282576B2 (en) | 2003-09-29 | 2012-10-09 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
| US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
| WO2005065414A2 (en) | 2003-12-31 | 2005-07-21 | Pelikan Technologies, Inc. | Method and apparatus for improving fluidic flow and sample capture |
| EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
| US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
| EP1765194A4 (en) | 2004-06-03 | 2010-09-29 | Pelikan Technologies Inc | Method and apparatus for a fluid sampling device |
| EP2265324B1 (en) | 2008-04-11 | 2015-01-28 | Sanofi-Aventis Deutschland GmbH | Integrated analyte measurement system |
| US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
| US8440693B2 (en) | 2009-12-22 | 2013-05-14 | Novartis Ag | Substituted isoquinolinones and quinazolinones |
| US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
| CN102060786A (en) * | 2011-01-20 | 2011-05-18 | 天津大学 | 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof |
| US9839684B2 (en) * | 2011-04-06 | 2017-12-12 | Biovaxim Limited | Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance |
| WO2013175417A1 (en) | 2012-05-24 | 2013-11-28 | Novartis Ag | Pyrrolopyrrolidinone compounds |
| US9556180B2 (en) | 2013-01-22 | 2017-01-31 | Novartis Ag | Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction |
| EP2948451B1 (en) | 2013-01-22 | 2017-07-12 | Novartis AG | Substituted purinone compounds |
| JP6373978B2 (en) | 2013-05-27 | 2018-08-15 | ノバルティス アーゲー | Imidazopyrrolidinone derivatives and their use in the treatment of diseases |
| ES2650562T3 (en) | 2013-05-28 | 2018-01-19 | Novartis Ag | Derivatives of pyrazolo-pyrrolidin-4-one and its use in the treatment of diseases |
| ES2656471T3 (en) | 2013-05-28 | 2018-02-27 | Novartis Ag | Pyrazolo-pyrrolidin-4-one derivatives as BET inhibitors and their use in the treatment of diseases |
| EP3071571A1 (en) | 2013-11-21 | 2016-09-28 | Novartis AG | Pyrrolopyrrolone derivatives and their use as bet inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102764A0 (en) * | 1991-08-16 | 1993-01-31 | Merck & Co Inc | Quinazoline derivatives,and pharmaceutical compositions containing them |
| WO1993004047A1 (en) * | 1991-08-16 | 1993-03-04 | Merck & Co., Inc. | Quinazoline derivatives as inhibitors of hiv reverse transcriptase |
| WO1993022292A1 (en) * | 1992-05-07 | 1993-11-11 | Merck & Co., Inc. | New quinazolines as inhibitors of hiv reverse transcriptase |
| US5665720A (en) * | 1992-08-07 | 1997-09-09 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
| DE4320347A1 (en) * | 1993-06-19 | 1994-12-22 | Boehringer Mannheim Gmbh | Quinazoline derivatives and medicaments containing them |
| GB2281297A (en) * | 1993-08-27 | 1995-03-01 | Merck & Co Inc | Quinazoline compounds |
| AU1046895A (en) * | 1993-11-05 | 1995-05-23 | Merck & Co., Inc. | New quinazolines as inhibitors of hiv reverse transcriptase |
| US5434152A (en) * | 1993-11-08 | 1995-07-18 | Merck & Co., Inc. | Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone |
-
1998
- 1998-03-19 HR HR60/071,322A patent/HRP980143A2/en not_active Application Discontinuation
- 1998-04-06 AR ARP980101558A patent/AR012340A1/en not_active Application Discontinuation
- 1998-04-07 JP JP54297198A patent/JP2002504095A/en active Pending
- 1998-04-07 CA CA002284996A patent/CA2284996A1/en not_active Abandoned
- 1998-04-07 PL PL98336305A patent/PL336305A1/en unknown
- 1998-04-07 IL IL13218898A patent/IL132188A0/en unknown
- 1998-04-07 NZ NZ500592A patent/NZ500592A/en unknown
- 1998-04-07 AU AU67960/98A patent/AU734928B2/en not_active Ceased
- 1998-04-07 EE EEP199900452A patent/EE9900452A/en unknown
- 1998-04-07 SK SK1378-99A patent/SK137899A3/en unknown
- 1998-04-07 WO PCT/US1998/006733 patent/WO1998045276A2/en not_active Application Discontinuation
- 1998-04-07 EP EP98913401A patent/EP0973753A2/en not_active Withdrawn
- 1998-04-07 KR KR1019997009225A patent/KR20010006146A/en not_active Application Discontinuation
- 1998-04-07 HU HU0001446A patent/HUP0001446A3/en unknown
- 1998-04-07 CN CN98803974A patent/CN1252063A/en active Pending
- 1998-04-07 EA EA199900907A patent/EA001991B1/en not_active IP Right Cessation
- 1998-04-07 BR BR9808513-1A patent/BR9808513A/en not_active IP Right Cessation
- 1998-04-15 TW TW087105365A patent/TW587078B/en active
-
1999
- 1999-10-08 NO NO19994904A patent/NO314936B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO994904D0 (en) | 1999-10-08 |
| PL336305A1 (en) | 2000-06-19 |
| AU6796098A (en) | 1998-10-30 |
| EA199900907A1 (en) | 2000-04-24 |
| BR9808513A (en) | 2000-05-23 |
| CN1252063A (en) | 2000-05-03 |
| SK137899A3 (en) | 2000-05-16 |
| EA001991B1 (en) | 2001-10-22 |
| TW587078B (en) | 2004-05-11 |
| HUP0001446A3 (en) | 2001-11-28 |
| EE9900452A (en) | 2000-04-17 |
| WO1998045276A2 (en) | 1998-10-15 |
| AU734928B2 (en) | 2001-06-28 |
| HUP0001446A2 (en) | 2001-05-28 |
| NO994904L (en) | 1999-12-01 |
| CA2284996A1 (en) | 1998-10-15 |
| KR20010006146A (en) | 2001-01-26 |
| EP0973753A2 (en) | 2000-01-26 |
| WO1998045276A3 (en) | 1999-01-14 |
| JP2002504095A (en) | 2002-02-05 |
| HRP980143A2 (en) | 1999-02-28 |
| IL132188A0 (en) | 2001-03-19 |
| NO314936B1 (en) | 2003-06-16 |
| NZ500592A (en) | 2001-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR012340A1 (en) | 3,4-DIHYDRO-2 (1H) -QUINAZOLINONES 4,4-DISSTITUTED USEFUL AS INHIBITORS OF THE REVERSE TRANSCRIPTASE OF HIV, COMPOSITION AND KITFARMACEUTICOS THAT CONTAIN THEM | |
| ECSP045229A (en) | PIRIDINONES REPLACED AS MODULATORS OF THE P38 MAP QUINASA | |
| PA8551001A1 (en) | NEW COMPOUNDS | |
| CO5600998A2 (en) | FLUOROPIRROLIDINS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA | |
| HUP0203450A2 (en) | Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
| ECSP055636A (en) | TIENYL-HYDROXAMIC ACIDS SUBSTITUTED, AND ITS USE TO TREAT DISEASES ASSOCIATED WITH THE ENZYMATIC ACTIVITY OF HISTONE DEACETILASE | |
| CO5580747A2 (en) | N-ADAMANTILMETILO DERIVATIVES AND INTERMEDIARIES AS PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION | |
| AR055878A1 (en) | CYCLOPROPANOCARBOXAMIDE DERIVATIVES | |
| BR0012646A (en) | Compound, oligonucleotide analogue or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and use of an oligonucleotide analog | |
| AR071043A1 (en) | L-GLUTAMIC ACID MARKED WITH (F -18), L- GLUTAMINE MARKED WITH (F-18), ITS DERIVATIVES AND ITS USE, AS WELL AS PROCEDURES FOR THEIR PREPARATION | |
| ES2087721T3 (en) | GUANIDINES SUBSTITUTED WITH (BENZODIOXANE, BENZOFURANE OR BENZOPYRANE) -ALKYLAMINE-RENT AS SELECTIVE VASOCONSTRICTORS. | |
| CR7956A (en) | INTERMEDIATE ANTIBACTERIAL INDOLONA OXAZOLIDINONES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| AR012489A1 (en) | CORTICOTROPIN RELEASE FACTOR THIOPHENOPYRIDINE ANTAGONISTS. PROCEDURE FOR ITS PREPARATION, THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM, PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITION, AN INTERMEDIATE COMPOUND AND | |
| CO5631434A2 (en) | DERIVATIVES OF PIRIDINA-CARBOXAMIDA AND ITS USE AS PESTICIDES | |
| PE58599A1 (en) | 2-AMINO-6- (4-PHENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED | |
| AR031774A1 (en) | NEW DERIVATIVES OF DIAMINOPIRAZOL AND ITS USE IN OXIDATION DYING OF KERATIN FIBERS | |
| PA8589801A1 (en) | AMINOALCOXYINDOLS | |
| PE20011349A1 (en) | 1-ARIL-4-OXO-1,4-DIHYDRO-3-QUINOLINE CARBOXAMIDES AS ANTIVIRAL AGENTS | |
| CO5050264A1 (en) | DERIVATIVES OF 6-AZAURACILO AS IL-5 INHIBITORS PROCEDURES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING SUCH DERIVATIVES | |
| AR054418A1 (en) | QUINAZOLINAS PIRAZOLAMINO SUBSTITUTED. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS. | |
| AR052663A1 (en) | HETEROCICLIC OXYM COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| CL2021002475A1 (en) | Fungicide formulations with reduced crystal growth. | |
| NO158256C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRISUBSTITUTED PYRIMIDO (5,4-D) PYRIMIDINES. | |
| RU2004130284A (en) | ANTI-PARASITIC ARTEMISININ DERIVATIVES (ENDOPEROXIDES) | |
| AR001995A1 (en) | DERIVATIVES OF BENZSOXAZOLE, PROCEDURES FOR ITS MANUFACTURE, ANTIPARASITIC AGENTS THAT CONTAIN THEM AS ACTIVE INGREDIENTS AND PROCEDURES FOR THE CONTROL OF PHYTOPATHOGENIC MICROORGANISMS, INSECTS AND MITES. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |